Crossmark

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial

Crossref DOI link: https://doi.org/10.1186/s12933-018-0716-x

Published Online: 2018-05-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tripolt, Norbert J.

Aberer, Felix

Riedl, Regina

Url, Jasmin

Dimsity, Gudrun

Meinitzer, Andreas

Stojakovic, Tatjana

Aziz, Faisal

Hödl, Ronald

Brachtl, Gabriele

Strunk, Dirk

Brodmann, Marianne

Hafner, Franz

Sourij, Harald
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02350478 at ClinicalTrials.gov

Documents that mention this clinical trial

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
https://doi.org/10.1186/s12933-018-0716-x
Funding

Funding for this research was provided by:

Oesterreichische Nationalbank (15941)
License Information

Text and Data Mining valid from 2018-05-17

Version of Record valid from 2018-05-17
More Information

Article History

Received: 27 February 2018

Accepted: 10 May 2018

First Online: 17 May 2018

Document is current

Any future updates will be listed below